Trump Administration Delivers Lucrative Win for Its Kratom Allies
The DEA has moved to classify specific kratom derivatives as controlled substances, even as reports emerge of administration support for the industry.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
The Drug Enforcement Administration is taking steps to place strong kratom-related products, specifically 7-OH and similar derivatives, under strict federal drug controls. This shift marks a significant policy change regarding the regulation of these substances.
Coverage from The New York Times, Reuters, The Center Square, WESH, and Citeline emphasizes a disconnect between the administration's policy actions and previous praise for natural 7-OH. Health officials and Florida leaders have expressed concerns regarding the distribution of these products.
Whether this move will lead to a total prohibition of the identified substances remains to be seen. Industry observers are monitoring the official DEA notice for specific enforcement timelines and the broader impact on the kratom market.
Synthesized by headlinez.news from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated just now.
Quick answers
What specific substances are targeted by the DEA?
The DEA is moving to control 7-OH and similar kratom derivatives.
What concerns have been raised by officials?
Florida leaders and health officials have raised concerns regarding 7-OH products.
Has the administration taken a consistent stance on kratom?
Coverage highlights a contrast between the Trump administration's past praise of natural 7-OH and the current DEA movement to ban it.
Coverage (8)
- Trump praised 'natural 7-OH'; DEA moves to ban it Barron News-Shield · 5h ago
- HHS, FDA Commend DEA Action Against Dangerous Enhanced 7-OH Products HHS.gov · 5h ago
- Drug Regulators Propose Scheduling Kratom Plant Derivative 7-OH Bloomberg Law News · 5h ago
- Shift In US Kratom Policy To Outlawing 7-OH, Similar Derivatives Reaches DEA Notice insights.citeline.com · 5h ago
- Trump praised 'natural 7-OH'; DEA moves to ban it The Center Square · 5h ago
- Florida leaders, health officials raise concerns about 7-OH products WESH · 5h ago
- DEA moves to place some strong kratom-related products under strict federal drug controls Reuters · 5h ago
- Trump Administration Delivers Lucrative Win for Its Kratom Allies The New York Times · 5h ago
Topics
Related trends
Trump administration silent on Iranian school strike four months later
Four months after a fatal school strike in Iran, reports from the AP and other outlets renew scrutiny regarding the Trump administration’s continued silence.
EXCLUSIVE: NATO joins exercises off US coast, even as it loses political fight in Trump's Washington
NATO conducts high-profile drills near U.S. shores as political divisions in Washington escalate
Trump to lift limits on Anthropic’s Fable model
The Trump administration has officially removed export controls previously restricting Anthropic's advanced AI models.
Another day, another illegal billion-dollar bribe to raise your electricity prices
Taxpayer-funded settlements are derailing offshore wind projects—raising questions about energy policy and corporate influence
Exclusive | Trump Administration Plans to Pay Smaller Meatpackers to Keep Slaughtering Cattle
USDA injects $500M into small meatpackers—while Tyson and JBS stocks dip under Trump-era aid plan
FDA Selects Seven Participants for PreCheck Pilot Program to Advance U.S. Drug Manufacturing
The FDA has launched its PreCheck pilot program, selecting seven participants to accelerate domestic drug manufacturing capabilities.